Sify.com » Topics » Halozyme
Halozyme News
Mattel, Endocyte, Ivanhoe are market movers
Stocks that moved substantially or traded heavily Monday on the New York Stock Exchange and Nasdaq Stock Market:NYSEChesapeake Energy Corp., down 76 cents at $19.19A Citi analyst downgraded the natural gas producer's stock saying that a drop in natural gas prices will cut into its value.Procter & Gamble Co., up 97 cents at $66.78The maker of Crest toothpaste and Gillette razors said that it is raising
Stocks that moved substantially or traded heavily Monday on the New York Stock Exchange and Nasdaq Stock Market:NYSEChesapeake Energy Corp., down 76 cents at $19.19A Citi analyst downgraded the natural gas producer's stock saying that a drop in natural gas prices will cut into its value.Procter & Gamble Co., up 97 cents at $66.78The maker of Crest toothpaste and Gillette razors said that it is raising
Halozyme completes Hylenex manufacturing probe
Halozyme Therapeutics Inc. said Tuesday it completed an investigation into manufacturing problems behind its Hylenex product and has drawn up a corrective action plan and market relaunch strategy.
Halozyme Therapeutics Inc. said Tuesday it completed an investigation into manufacturing problems behind its Hylenex product and has drawn up a corrective action plan and market relaunch strategy.
Halozyme narrows 4Q loss due to Hylenex payment
Biotechnology company Halozyme Therapeutics Inc. said Friday that it trimmed its fourth-quarter loss with help from a large payment from its partner Baxter International and Swiss drug maker Roche.
Biotechnology company Halozyme Therapeutics Inc. said Friday that it trimmed its fourth-quarter loss with help from a large payment from its partner Baxter International and Swiss drug maker Roche.
Halozyme takes bigger loss on testing expenses
Biotechnology company Halozyme Therapeutics Inc. reported a bigger third-quarter loss on Friday, as it started clinical trials of a fast-acting insulin during the period.
Biotechnology company Halozyme Therapeutics Inc. reported a bigger third-quarter loss on Friday, as it started clinical trials of a fast-acting insulin during the period.
© Copyright Sify Technologies Ltd, 1998-2011. All rights reserved. India News Portal, Sify.com hosted at SifyHosting India's first Level 3 Internet Data Centre.
Site optimized for Internet Explorer 5.5 and above.
See Disclaimer |Privacy Policy &Parental Guidance on pornography |careers@sify |About Us |Feedback |Advertise
Site optimized for Internet Explorer 5.5 and above.
See Disclaimer |Privacy Policy &Parental Guidance on pornography |careers@sify |About Us |Feedback |Advertise